UCLA Health’s new leading-edge theranostics center that uses targeted radioactive drugs to treat advanced cancer is now open. The center, which opened Feb. 13, will mostly treat advanced prostate cancer but will also see people with thyroid cancer and neuroendocrine tumors.
